Brief: Maia Biotechnology Reports Third Quarter 2022 Financial Results
09/11/2022 21:29
Nov 9 (Reuters) - Maia Biotechnology Inc MAIA.A :
* MAIA BIOTECHNOLOGY REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* MAIA BIOTECHNOLOGY - CURRENT CASH, WHICH INCLUDED PROCEEDS
FROM
IPO COMPLETED IN JULY 2022, IS ANTICIPATED TO FUND OPERATIONS
FOR THE NEXT 12 MONTHS
Source text for Eikon: ID:nBw66wqPsa
Further company coverage: MAIA.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Maia Biotechnology
See all newsBrief: Maia Biotechnology Says Ateganosine Plus Cemiplimab Outperforms Standard Chemotherapy Dcr In 3l Nsclc
Brief: Maia Biotechnology - To Terminate At The Market Offering Agreement Effective May 23, 2026 - SEC Filing
Brief: Maia Biotechnology Reports Overall Survival Exceeding Two Years For Eight Patients In Ongoing Phase 2 Clinical Trial In Non-Small Cell Lung Cancer
Brief: Maia Biotechnology Inc Enters Underwriting Agreement With Konik Capital Partners - SEC Filing
MAIA Biotechnology plunges after $30 million share sale